The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Immune response and inflammatory pathway of ulcerative colitis
Abstract
Ulcerative colitis (UC) is an idiopathic relapsing inflammatory disease. Although the etiology of UC remains unclear, it could be characterized by inflammation of the intestinal mucosa, starting from the rectum and potentially involving the entire colon. The immune response and inflammatory pathway of UC have shown that tissue damage is driven by dynamic and complexes of cells and cytokines. Various types of cells, including antigen-presenting cells (dendritic cells and macrophages), T helper cells, regulatory T cells, and natural killer T cells, play a crucial role in UC pathogenesis by regulation, suppression, and maintenance of inflammation. Moreover, cytokine networks become an important part due to their signaling function, which is indispensable for cell communication. Pro-inflammatory cytokines [tumor necrosis factor-α, interleukin (IL)-1, IL-6, IL-9, IL-13, and IL-33] play significant roles in upregulation, while anti-inflammatory cytokines (transforming growth factor-β, IL-10, and IL-37) play significant roles in downregulation of disease progression. The pathogenesis of UC consists of immuno-inflammatory pathways related to the multiple components of the intestine, including the epithelial barrier, commensal microflora, antigen recognition, dysregulation of immunological responses, leukocyte recruitment, and genetic factors. The understanding of immuno-inflammatory pathways of UC might lead to the development of a specific therapy and/or a novel treatment that could be more efficient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Biologic targeting in the treatment of inflammatory bowel diseases
Ardizzone, S. (2009) · Biologics · doi:10.2147/btt.2009.2855 · Cited by 133
RetractedFord Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Glocker, E.-O., Kotlarz, D., Boztug, K., Gertz, E. M., Schäffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., Allroth, A., Murugan, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907206 · Cited by 1,461
The gastrointestinal mucus system in health and disease
Johansson, M. E. V., Sjövall, H., & Hansson, G. C. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.35 · Cited by 1,438
Cario, E., & Podolsky, D. K. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7010-7017.2000 · Cited by 1,246
HELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Kaplan, G. G., & Ng, S. C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.020 · Cited by 1,224
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Strober, W., & Fuss, I. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.016 · Cited by 1,102
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., & Strober, W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00453-3 · Cited by 650
Frank, D. N., Robertson, C. E., Hamm, C. M., Kpadeh, Z., Zhang, T., Chen, H., Zhu, W., Sartor, R. B., Boedeker, E. C., Harpaz, N., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21339 · Cited by 594
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases
Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A., & Stagg, A. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.013 · Cited by 564
The UK IBD Genetics Consortium, & The Wellcome Trust Case Control Consortium 2 (2009) · Nature Genetics · doi:10.1038/ng.483 · Cited by 536
Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
panés, J., & Granger, D. N. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70328-2 · Cited by 370
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., Oostingh, G. J., Pfaller, T., Pixner, C., Posselt, G., et al. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0288 · Cited by 357
Head, K. A., & Jurenka, J. S. (2003) · PubMed · Cited by 336
Reimund, J. M., Wittersheim, C., Dumont, S., Muller, C. D., Baumann, R., Poindron, P., & Duclos, B. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01540912 · Cited by 281
Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation
Luettig, J., Rosenthal, R., Barmeyer, C., & Schulzke, J. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.977176 · Cited by 277
Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis
Uguccioni, M., Gionchetti, P., Robbiani, D. F., Rizzello, F., Peruzzo, S., Campieri, M., & Baggiolini, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65128-0 · Cited by 275
XII. IL-10-deficient (IL-10−/−) mice and intestinal inflammation
Rennick, D. M., & Fort, M. M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g829 · Cited by 225
Kamada, N., Hisamatsu, T., Okamoto, S., Sato, T., Matsuoka, K., Arai, K., Nakai, T., Hasegawa, A., Inoue, N., Watanabe, N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6900 · Cited by 215
McAlindon, M. E., Hawkey, C. J., & Mahida, Y. R. (1998) · Gut · doi:10.1136/gut.42.2.214 · Cited by 193
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Interleukin 8: cells of origin in inflammatory bowel disease.
Grimm, M. C., Elsbury, S. K., Pavli, P., & Doe, W. F. (1996) · Gut · doi:10.1136/gut.38.1.90 · Cited by 185
The genetics of inflammatory bowel disease
Ahmad, T., Satsangi, J., McGovern, D. P. B., Bunce, M., & Jewell, D. P. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00981.x · Cited by 184
IL-9 and its receptor are predominantly involved in the pathogenesis of UC
Nalleweg, N., Chiriac, M. T., Podstawa, E., Lehmann, C., Rau, T. T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-305947 · Cited by 181
Muthas, D., Reznichenko, A., Balendran, C. A., Böttcher, G., Clausen, I. G., Kärrman Mårdh, C., Ottosson, T., Uddin, M., MacDonald, T. T., Danese, S., et al. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1235224 · Cited by 178
The Role of Environmental Factors in the Pathogenesis of Inflammatory Bowel Diseases: A Review
Shouval, D. S., & Rufo, P. A. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.2571 · Cited by 174
Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease
Kmieć, Z., Cyman, M., & Ślebioda, T. J. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.09.001 · Cited by 168
Osawa, Y., Banno, Y., Nagaki, M., Brenner, D. A., Naiki, T., Nozawa, Y., Nakashima, S., & Moriwaki, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.173 · Cited by 164
Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis
Melgar, S., Yeung, M. M., Bas, A., Forsberg, G., Suhr, O. B., Öberg, Å., Hammarström, S., Danielsson, Å., & Hammarström, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02268.x · Cited by 160
Inflammatory pathways of importance for management of inflammatory bowel disease
Pedersen, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.64 · Cited by 158
Implication of TNF-Related Apoptosis-Inducing Ligand in Inflammatory Intestinal Epithelial Lesions
Bègue, B., Wajant, H., Bambou, J., Dubuquoy, L., Siegmund, D., Beaulieu, J., Canioni, D., Berrebi, D. D., Brousse, N., Desreumaux, P., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.022 · Cited by 153
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases
Abraham, C., Dulai, P. S., Vermeire, S., & Sandborn, W. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.018 · Cited by 152
IL-33 is upregulated in colonocytes of ulcerative colitis
Seidelin, J. B., Bjerrum, J. T., Coskun, M., Widjaya, B., Vainer, B., & Nielsen, O. H. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.11.001 · Cited by 147
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications
Mudter, J., & Neurath, M. F. (2006) · Gut · doi:10.1136/gut.2005.090464 · Cited by 139
Lawrance, I. C., Maxwell, L. E., & Doe, W. F. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200102000-00003 · Cited by 128
Optimising monitoring in the management of Crohn's disease: A physician's perspective
Papay, P., Ignjatovic, A., Κarmiris, K., Amarante, H. M. B. D. S., Miheller, P., Feagan, B. G., D’Haens, G., Marteau, P. R., Reinisch, W., Sturm, A., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.02.005 · Cited by 119
Epithelial expression of interleukin-37b in inflammatory bowel disease
Imaeda, H., Takahashi, K., Fujimoto, T., Kasumi, E., Ban, H., Bamba, S., Sonoda, H., Shimizu, T., Fujiyama, Y., & Andoh, A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12061 · Cited by 118
IL-33 and the intestine: The good, the bad, and the inflammatory
Hodzic, Z., Schill, E. M., Bolock, A. M., & Good, M. L. (2017) · Cytokine · doi:10.1016/j.cyto.2017.06.017 · Cited by 117
Cytokines in inflammatory bowel disease
Moldoveanu, A. C., Diculescu, M., & Fierbinteanu-Braticevici, C. G. (2015) · Romanian Journal of Internal Medicine · doi:10.1515/rjim-2015-0016 · Cited by 113
ZOTTO, B. D., Mumolo, G. M., Pronio, A., Montesani, C., Tersigni, R., & Boirivant, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02250.x · Cited by 104
Matsuda, R., Koide, T., Tokoro, C., Yamamoto, T., Godai, T., Morohashi, T., Fujita, Y., Takahashi, D., Kawana, I., Suzuki, S., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20759 · Cited by 103
The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease
Li, Y., Wang, Y., Liu, Y., Wang, Y., Zuo, X., Li, Y., & Lu, X. (2014) · Mediators of Inflammation · doi:10.1155/2014/136329 · Cited by 101
Shen, X.-Y., Shi, R., Zhang, H., Li, K., Zhao, Y., & Zhang, R. (2010) · Digestion · doi:10.1159/000260417 · Cited by 75
Intestinal Antigen-Presenting Cells
Flannigan, K. L., Geem, D., Harusato, A., & Denning, T. L. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.024 · Cited by 57
Cellular and molecular mechanisms of immune dysregulation and autoimmunity
Azizi, G., Rastegari‐Pouyani, M., Abolhassani, H., Sharifi, L., Zaki‐Dizaji, M., Mohammadi, J., Mirshafiey, A., & Aghamohammadi, A. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.08.012 · Cited by 48
Significance of serum Il-9 levels in inflammatory bowel disease
Defendenti, C., Sarzi‐Puttini, P., Saibeni, S., Bollani, S., Bruno, S., Almasio, P. L., Declich, P., & Atzeni, F. (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015600535 · Cited by 40
Rahman, A., Fahlgren, A., Sitohy, B., Baranov, V. I., Zirakzadeh, A. A., Hammarström, S., Danielsson, Å., & Hammarström, M. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20141 · Cited by 38
Ashwood, P., Harvey, R., Verjee, T., Wolstencroft, R. A., Thompson, R. P. H., & Powell, J. J. (2004) · Inflammation Research · doi:10.1007/s00011-003-1219-z · Cited by 33
Gundersen, M. D., Goll, R., Fosse, J. H., Olsen, T., Rismo, R., Sørbye, S. W., Sundnes, O., Haraldsen, G., & Florholmen, J. (2016) · Scientific Reports · doi:10.1038/srep35403 · Cited by 24
Hufford, M. M., & Kaplan, M. H. (2014) · Nature Immunology · doi:10.1038/ni.2916 · Cited by 22
Cited by
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
Guo, X. Y., Liu, X. J., & Hao, J. Y. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12849 · Cited by 336
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Tatiya-aphiradee, N., Chatuphonprasert, W., & Jarukamjorn, K.
- Venue
- Journal of Basic and Clinical Physiology and Pharmacology
- Publisher
- Walter de Gruyter GmbH
- Published
- 2018-07-31
- Volume
- 30
- Issue
- 1
- Pages
- 1-10
- ISSN
- 0792-6855 (ISSN-L)
- 2191-0286
- OpenAlex
- W2886213241
- Cited by
- 368
- References
- 57
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.